Related Experiment Video
Updated: Jun 16, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Symplekin promotes tumorigenicity by up-regulating claudin-2 expression
Michael Buchert1, Marina Papin, Caroline Bonnans
1Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5203, Institut National de la Santé et de la Recherche Médicale U661, and Université Montpellier 1 and 2, Montpellier F-34094, France.
Nuclear symplekin overexpression promotes colorectal cancer (CRC) by regulating claudin-2 and ZONAB. Reducing symplekin inhibits CRC cell growth and tumorigenicity, highlighting its potential as a therapeutic target.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Symplekin is a protein involved in RNA polyadenylation and transcriptional regulation, localized at epithelial tight junctions.
- Nuclear symplekin interacts with ZONAB to promote cell cycle gene transcription and inhibit intestinal cell differentiation.
- High nuclear symplekin levels are observed in human colorectal cancer (CRC) samples.
Purpose of the Study:
- To investigate the role of nuclear symplekin in colorectal cancer (CRC) development and progression.
- To elucidate the molecular mechanisms by which symplekin influences CRC cell behavior and tumorigenicity.
- To determine the relationship between symplekin, ZONAB, and claudin-2 in CRC.
Main Methods:
- shRNA-mediated reduction of symplekin expression in HT-29 CRC cells.
- Analysis of cell proliferation, anchorage-independent growth, and tumorigenicity in vivo.
- Assessment of tight junction (TJ) ion transport, cell polarization, and ZONAB localization.
- siRNA-mediated down-regulation of ZONAB and claudin-2.
- Virus-mediated restoration of claudin-2 expression.
Main Results:
- Symplekin down-regulation significantly decreased CRC cell proliferation, anchorage-independent growth, and tumorigenicity.
- Symplekin depletion altered TJ ion transport, promoted ZONAB membrane localization, and enhanced cell polarization.
- Claudin-2 expression was reduced upon symplekin down-regulation, an effect mimicked by ZONAB depletion.
- Restoration of claudin-2 rescued phenotypic alterations induced by symplekin depletion.
- Claudin-2 down-regulation mimicked symplekin depletion effects on transepithelial resistance, cyclin D1 expression, and ZONAB localization.
Conclusions:
- Nuclear overexpression of symplekin promotes human colon tumorigenesis.
- Regulation of claudin-2 expression is a key mechanism by which symplekin drives CRC.
- Symplekin represents a potential therapeutic target for colorectal cancer.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Pleiotropy